Evidence map›Paper›PMID 40305378›Full record

ArticleJournal of genetic counseling2025

Call to action for genetic counseling research in hereditary cancer: Considerations from the evidence-based guidelines development process.

Brooke Levin, Erin Salo-Mullen, Julie O Culver, Raluca N Kurz, Pamela Brock, Rochelle Demsky, Stacy Lloyd, Ghecemy Lopez, Phuong L Mai, Kami Wolfe Schneider

Abstract read
In one paragraph

Article in Journal of genetic counseling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brooke LevinMD Anderson Cancer Center at Cooper, Cooper University Hospital, Camden, New Jersey, USA.ORCID 0000-0001-5255-0694
Erin Salo-MullenMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Julie O CulverUSC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Raluca N KurzCollege of Science and Health, Charles R. Drew University of Medicine and Science, Los Angeles, California, USA.
Pamela BrockDepartment of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
Rochelle DemskyLifeLabs Genetics, Toronto, Ontario, Canada.
Stacy LloydVHL Alliance, Boston, Massachusetts, USA.
Ghecemy LopezCelebrate Life Cancer Ministry, Hawthorne, California, USA.
Phuong L MaiCenter for Clinical Genomics and Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Kami Wolfe SchneiderDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The National Society of Genetic Counselors (NSGC) planned to develop an evidence-based guideline on the outcomes of genetic counseling for individuals at risk for hereditary cancer. The practice guideline workgroup used Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology including ranking the importance of outcomes of genetic counseling for individuals at risk for hereditary cancer. However, due to evidence gaps in the literature, particularly the limited availability of high quality and well-designed studies for many important outcomes of genetic counseling, the NSGC identified a need for additional research prior to guideline development. Herein, we describe a "call to action" for future research, particularly for health services-related outcomes of genetic counseling in diverse populations. Identified research priorities include conducting high-quality studies that separate the outcomes of genetic counseling from genetic testing, assessing outcomes associated with pre- and/or post-test genetic counseling, measuring patient-reported and health system-reported outcomes, comparing genetic counseling by certified genetic counselors versus non-genetics-trained providers, differentiating need in various hereditary cancer indications, and identifying barriers to genetic counseling in historically excluded patient communities.

Indexed as

Genetic CounselingNeoplasmsPractice Guidelines as TopicEvidence-Based MedicineGenetic TestingHumansevidence‐based guidelinesgenetic counselinggenetic testinghereditary cancerrisk assessment

Identifiers

PMID40305378
PMCPMC12043037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.